Literature DB >> 9107663

Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging.

M T Keogan1, V J Lowe, M E Baker, V G McDermott, H K Lyerly, R E Coleman.   

Abstract

BACKGROUND: Positron emission tomography (PET) with F-18 fluorodeoxyglucose (FDG) is a useful technique for detection of malignancy. The purpose of this study was to determine if FDG-PET scanning using visual and quantitative analyses can identify patients with recurrent colorectal tumor following abdominoperineal resection.
METHODS: Eighteen patients were evaluated for possible local recurrence of rectal carcinoma following abdominoperineal resection. The clinical presentation included rising carcinoembryonic antigen levels (n = 5), increasing size of a presacral mass on computed tomography or magnetic resonance (n = 13), or local symptoms (n = 3). Axial PET images of the pelvis were obtained following an injection of 10 mCi of FDG prior to biopsy. Quantitative analysis was performed by calculation of a standardized uptake ratio (SUR), and the images were interpreted by two radiologists in consensus. FDG-PET findings were correlated with histological or cytological findings and with the clinical outcome.
RESULTS: Recurrent malignancy was confirmed in 13 patients by surgery (n = 8) or percutaneous biopsy (n = 5). Benign lesions were confirmed in five patients by surgery (n = 1), biopsy (n = 3), or clinical follow up (n = 1). Visual analysis of the FDG-PET data had a sensitivity of 92.3% (12/13) for recurrent disease (95% confidence limits; 63.9%, 99.8%) and a specificity of 80% (4/5; 95% confidence limits; 28.3%, 99.4%). SUR values were significantly higher in malignant lesions (range = 2.92-19.74, mean = 6.89) than in benign ones (range = 1.40-3.47, mean = 1.96; p = 0.002).
CONCLUSION: FDG-PET is an accurate technique for detection of locally recurrent colorectal carcinoma. Visual analysis is equivalent to quantitative analysis for detection of disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9107663     DOI: 10.1007/s002619900202

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  8 in total

1.  Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography.

Authors:  D H Park; K H Kim; S Y Park; B H Lee; C W Choi; S Y Chin
Journal:  Korean J Radiol       Date:  2000 Jan-Mar       Impact factor: 3.500

2.  Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer.

Authors:  M Bellomi; S Rizzo; L L Travaini; L Bazzi; G Trifirò; M G Zampino; D Radice; G Paganelli
Journal:  Radiol Med       Date:  2007-07-26       Impact factor: 3.469

3.  Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?

Authors:  Ludwig G Strauss; Sven Klippel; Leyun Pan; Klaus Schönleben; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-12       Impact factor: 10.057

4.  FDG-PET in colorectal cancer.

Authors:  Lioe-Fee de Geus-Oei; Theo J M Ruers; Cornelis J A Punt; Jan Willem Leer; Frans H M Corstens; Wim J G Oyen
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

5.  Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan.

Authors:  Byung Ik Jang
Journal:  Clin Endosc       Date:  2012-06-30

6.  The Clinical Meaning of Benign Colon Uptake in (18)F-FDG PET: Comparison with Colonoscopic Findings.

Authors:  Sun Hee Roh; Sung-Ae Jung; Seong-Eun Kim; Hye-In Kim; Min Jin Lee; Chung Hyun Tae; Ju Young Choi; Ki-Nam Shim; Hye-Kyung Jung; Tae Hun Kim; Kwon Yoo; Il Hwan Moon; Bom Sahn Kim
Journal:  Clin Endosc       Date:  2012-06-30

7.  Lesion Location in Clinical Significance of Incidental Colorectal FDG Uptake.

Authors:  Joseph C Lee; Gemma F Hartnett; Aravind S Ravi Kumar
Journal:  Clin Endosc       Date:  2012-11-30

Review 8.  Radiologic Imaging Modalities for Colorectal Cancer.

Authors:  Wen Liu; An-Rong Zeng; Han-Zhou Tang; Jin-Wei Qiang
Journal:  Dig Dis Sci       Date:  2021-07-30       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.